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INFLUENCE OF SOME OSTEOTROPIC FACTORS ONMODULATION OF THE
RANKL2 ISOFORM
S. Kwan Tat1, J.-P. Pelletier1, C. Ruiz-Velasco2, M. Padrines2, Y. Fortun2,
F. Mineau1, J. Martel-Pelletier1
1Univ. of Montreal Hosp. Res. Ctr. (CRCHUM), Montreal, QC, Canada;
2Université de Nantes, Laboratoire de Physiopathologie de la Résorption
Osseuse et Thérapie des Tumeurs Osseuses Primitives, Nantes, France
Purpose: Bone homeostasis is controlled by some members of the TNF
family, of which RANKL is an essential factor for mediating bone resorption.
RANKL exists as three isoforms, RANKL1, 2, and 3, and very little is known
about their regulation and modulation. A recent study by our group on
human normal and osteoarthritic subchondral bone osteoblasts [1] showed
that these cells differentially express membranous RANKL as well as
RANKL1 and RANKL3 isoforms, and that RANKL is differentially regulated
by some osteotropic factors. In that study, speciﬁc human RANKL2 cDNA
primers could not be designed, thus its expression could not be determined.
Here we investigated the RANKL2 protein modulation upon treatment with
the osteotropic factors TNF-α, vitamin D3 and PTH through a mechanistic
model, i.e. human cells that do not constitutively produce RANKL but were
stably transfected with cDNA of the RANKL2 isoform.
Methods: Human embryonic kidney 293 cells, which do not express RANKL,
were stably transfected with the cDNA encoding the transmembranous and
extracellular domain of murine RANKL. Semi-quantitative PCR and Western
Blot were used to determine the level of RANKL2 on the 293 and 293
RANKL2 cells. For the modulation experiments, the 293 RANKL2 cells were
incubated for 72 hours with TNF-α (5 ng/ml), vitamin D3 (50 nM), or
PTH (100 nM). For protein stability determination, cells were pretreated
with or without actinomycin D (5 μg/ml) for 1 hour and then incubated
(0-24 hours) with the above factors with or without actinomycin D. The
production of RANKL2 protein was determined in the cell lysates by a
speciﬁc DUOset ELISA.
Results: Expression and production analyses conﬁrmed that the 293
RANKL2 cells strongly expressed and produced RANKL2. Data showed that
TNF-α signiﬁcantly increased (p<0.03) RANKL2 production, but vitamin D3
and PTH had no effect. Treatment with vitamin D3 and PTH in conjunction
with actinomycin D had no effect on the stability of the RANKL2 protein.
However, TNF-α plus actinomycin D increased the stability of RANKL2
by increasing its half-life, and statistically signiﬁcant difference (p<0.005)
between actinomycin D alone and actinomycin D plus TNF-α was reached
at a 4-hour incubation period.
Conclusions: Our study brings to light that the RANKL2 isoform can be
modulated by TNF-α, a factor highly implicated in some diseases involving
bone resorption and an increase in RANKL activity, such as rheumatoid
arthritis. Interestingly, other osteotropic factors, vitamin D3 and PTH, did
not modulate RANKL2 protein production or its stability/half-life, which
could reﬂect the differential effects of these factors in bone remodelling.
These ﬁndings, in addition to the previous study [1], reveal that all
three RANKL isoforms can be modulated, which strongly suggests that
modulation of a speciﬁc RANKL isoform may be useful for a possible
classiﬁcation of certain osteolytic diseases and/or to assist in identifying
speciﬁc therapeutic treatments.
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Purpose: Altered bone remodeling is important in the initiation of os-
teoarthritis (OA). This may be due to the abnormal phenotype markers and
proliferation of human OA osteoblasts (Ob). The canonical Wnt/β-catenin
signaling pathway is crucial for osteogenesis and we previously demon-
strated that it is reduced in OA. n-3 or n-6 polyunsaturated fatty acids
(PUFAs) affect bone health status and can modify cell markers. Moreover,
recent data suggest bone marrow lesions, which are linked with OA, are
also more prominent in presence of n-6 PUFAs or monounsaturated lipids.
Here we questioned if alterations of lipids in OA Ob could alter their
phenotype, Wnt/β-catenin signaling, and mineralization.
Methods: We prepared primary human subchondral osteoblasts from tibial
plateaus of OA patients undergoing total knee arthroplasty. OA Ob were
incubated for a week in presence of 50 μg/ml of oleate (C18:1), linoleate
(C18:2, n-6 PUFA), linolenate (C18:3, n-3 PUFA), or vehicle. We evaluated
the role of these lipids on alkaline phosphatase and osteocalcin expression
and production, prostaglandin E2 (PGE2) production, and mineralization.
We determined expression of selected genes by qRT-PCR, alkaline phos-
phatase activity by substrate analysis, osteocalcin levels using a selective
EIA, and PGE2 using an ELISA. Wnt3a-dependent Wnt signaling was mea-
sured using the TOPﬂash TCF/lef reporter assay. Mineralization in presence
of the different lipids was assessed by Alizarin red staining in response to
10 ng/ml BMP-2, 10 ng/ml Dexamethasone (Dex), or their combination.
Results: Lipids modiﬁed the expression and production of alkaline phos-
phatase and osteocalcin in OA Ob. Oleate increased alkaline phosphatase
whereas linolenate decreased it. Oleate and linoleate both increased osteo-
calcin release whereas linolenate decreased it as for alkaline phosphatase
activity. Oleate and linoleate both triggered PGE2 production in normal
Ob to levels observed in high OA Ob, and these treatments increased
PGE2 levels in both low and high OA Ob to similar levels. In contrast,
linolenate did not alter PGE2 production by normal and low OA Ob yet
reduced it in high OA Ob. Wnt3a-dependent Wnt signaling remained
similar amongst the different lipid additions. While neither BMP-2 nor Dex
alone modiﬁed signiﬁcantly the mineralization of OA Ob, their combination
enhanced it. Oleate slightly increased the mineralization potential of OA
Ob in presence of BMP-2 and Dex whereas linoleate and linolenate did not
modify signiﬁcantly the response of OA Ob to combined BMP-2 and Dex
treatments.
Conclusions: These results suggest that acute treatment with monounsat-
urated lipids and n-6 PUFAs can exacerbate the altered phenotype of OA
Ob and modify that of normal Ob. Monounsaturated and n-6 PUFAs also
contributed to increase PGE2 production in normal and OA Ob while n-3
PUFAs stabilized PGE2 production. Surprisingly, monounsaturated lipids
could also improve the mineralization potential of OA Ob. In contrast, n-3
PUFAs improved the phenotype of OA Ob while having modest effect on
mineralization. Hence, an altered lipid environment and/or metabolism in
OA bone tissue could contribute to the abnormal phenotype of osteoblasts
and to alter their mineralization capacity.
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Purpose: Osteoarthritis involves cartilage and bone changes although the
role of bone in the pathophysiology is still unclear. We have previously
shown that inhibition of bone resorption had a protective effect on os-
teoarthritis induced in mice with high bone remodelling, suggesting that
level of bone remodelling might inﬂuence cartilage damage. The aim of this
study was to evaluate the effect of bone remodelling activity on cartilage
degradation ex vivo in human explants.
Methods: explants of bone and cartilage were harvested from healthy
zones in patients undergoing total replacement therapy for unicompar-
timental knee OA. Bone and articular cartilage were separated manually
and cultured in parallel in red-phenol-free medium. Bone explants were
cultured BGJb, and cartilage in DMEM. After 24h of stimulation with IL-1β
(10ng/ml), bone explants were cultured in presence of estradiol at 10 or
1000 nM or pamidronate at 1μM for 72h. After changing the medium
for 24h, bone culture supernatant was transferred on cartilage explants
previously stimulated by IL-1β for 24h (ratio 1:3). Control cartilage explants
were cultured with the same ratio of BGJb. Estradiol and pamidronate was
also directly cultured with cartilage explants to test a possible direct effect
of these drugs on cartilage catabolism. Proteoglycan (using the dimethyl-
methylene blue colorimetric assay) and aggrecan neoepitops (by western
blotting (WB) targeting the ARGSV sequence) release in the supernatant
were measured as cartilage catabolism markers.
Results: IL-1β on human cartilage explants induced an increase in proteo-
glycan release (124±2.4% p=0.037) when compared to controls. Supernatant
